154 related articles for article (PubMed ID: 2032422)
41. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
[TBL] [Abstract][Full Text] [Related]
42. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
[TBL] [Abstract][Full Text] [Related]
43. Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.
Egan SE; McClarty GA; Jarolim L; Wright JA; Spiro I; Hager G; Greenberg AH
Mol Cell Biol; 1987 Feb; 7(2):830-7. PubMed ID: 3102946
[TBL] [Abstract][Full Text] [Related]
44. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
45. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.
Nicolson GL; Gallick GE; Spohn WH; Lembo TM; Tainsky MA
Oncogene; 1992 Jun; 7(6):1127-35. PubMed ID: 1594244
[TBL] [Abstract][Full Text] [Related]
46. Production of the metastatic phenotype by DNA transfection in a rat mammary model.
Davies BR; Barraclough R; Davies MP; Rudland PS
Cell Biol Int; 1993 Sep; 17(9):871-9. PubMed ID: 8220314
[TBL] [Abstract][Full Text] [Related]
47. ras oncogene activation in mammary carcinomas induced by N-methyl-N-nitrosourea in Copenhagen rats.
Lu SJ; Archer MC
Mol Carcinog; 1992; 6(4):260-5. PubMed ID: 1485917
[TBL] [Abstract][Full Text] [Related]
48. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
Schlatter B; Waghorne CG
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
[TBL] [Abstract][Full Text] [Related]
49. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
Waghorne C; Kerbel RS; Breitman ML
Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
[TBL] [Abstract][Full Text] [Related]
50. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.
Cha RS; Thilly WG; Zarbl H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3749-53. PubMed ID: 8170982
[TBL] [Abstract][Full Text] [Related]
51. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
[TBL] [Abstract][Full Text] [Related]
52. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
[TBL] [Abstract][Full Text] [Related]
53. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A.
Kawamata H; Kameyama S; Kawai K; Tanaka Y; Nan L; Barch DH; Stetler-Stevenson WG; Oyasu R
Int J Cancer; 1995 Nov; 63(4):568-75. PubMed ID: 7591268
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas.
Stoesz SP; Gould MN
Oncogene; 1995 Dec; 11(11):2233-41. PubMed ID: 8570173
[TBL] [Abstract][Full Text] [Related]
55. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
[TBL] [Abstract][Full Text] [Related]
56. Induction of mouse mammary tumours in a transplantation system by the sequential introduction of the myc and ras oncogenes.
Bradbury JM; Sykes H; Edwards PA
Int J Cancer; 1991 Jul; 48(6):908-15. PubMed ID: 1860737
[TBL] [Abstract][Full Text] [Related]
57. Tn antigen is a pre-cancerous biomarker in breast tissue and serum in n-nitrosomethylurea-induced rat mammary carcinogenesis.
Babino A; Oppezzo P; Bianco S; Barrios E; Berois N; Navarrete H; Osinaga E
Int J Cancer; 2000 Jun; 86(6):753-9. PubMed ID: 10842187
[TBL] [Abstract][Full Text] [Related]
58. Correlation of differences in modulation of ras expression with metastatic competence of mouse mammary tumor subpopulations.
Shekhar PV; Miller FR
Invasion Metastasis; 1994-1995; 14(1-6):27-37. PubMed ID: 7657520
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
60. Studies of beta-casein content of normal and neoplastic rat mammary tissues by a homologous radioimmunoassay.
Edery M; Houdebine LM; Djiane J; Kelly PA
Mol Cell Endocrinol; 1984 Feb; 34(2):145-51. PubMed ID: 6714512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
